Congratulations to the EPiTOMISE Homa Bay-based study team for enrolling the first child participants in the trial. The EPiTOMISE study comparing malaria chemoprevention strategies in children with sickle-cell anemia in Kenya.

After 1.5 years of planning, the first participant was enrolled and randomized on January 29, and several more have followed soon after. Congratulations and thanks to our team members in Homa Bay and Eldoret.